Nomic joins the HESI Global OASIS Consortium to Advance Human-Relevant Safety Assessment Through Proteomics

Nomic Bio Inc. has teamed up with the Health and Environmental Sciences Institute’s OASIS Consortium to advance human-relevant safety assessments using proteomics. This collaboration will analyze over 3,000 human liver samples to create proteomic training datasets for new toxicity prediction methods, leveraging AI. This initiative could revolutionize how we assess the safety of chemicals and drugs, making the process more efficient and human-relevant. It underscores a significant step forward in the field of toxicology and could lead to better regulatory frameworks for safety evaluation.